schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: 15 patients with schizophrenia treated with a common drug and an Cuscuta epit?ymum capsule. Patients received their current treatment (atypical antipsychotic risper
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The definitive diagnosis of schizophrenia based on DSM-V criteria by clinical interview The use of a second-generation antipsychotic drug as the main treatment for schizophrenia Provide written consent from the patient and his guardian to enter the study
Exclusion criteria
Exclusion criteria: People with various types of mood disorders such as Bipolar disorder and depression Neurological disorders such as Parkinson's which are diagnosed by a neurologist. Mental retardation Blindness & Deafness Substance abuse in the last 6 months The occurrence of any unwanted side effects leading to a major clinical disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive symptoms- Delusions and hallucination. Timepoint: 0, 4 and 8 weeks. Method of measurement: Positive and Negative Syndrome Scale.;Negative Symptoms. Timepoint: 0, 4 and 8 weeks. Method of measurement: Positive and Negative Syndrome Scale.;Cognitive symptoms based on the cognitive grading scale of schizophrenia. Timepoint: 0, 4 and 8 weeks. Method of measurement: Schizophrenia Cognition Rating Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaedeh Parvizi
University of social welfare and rehabilitation sciences
Outcome results
None listed